serogroup B meningococcal vaccine (Bexsero) Report issue

Vaccine Approved FDA
AACT

Active Ingredient History

NOW
  • Now
Meningococcal vaccine refers to any vaccine used to prevent infection by Neisseria meningitidis. Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-135, and Y. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

menb | menbvac | recombinant neisseria meningitidis group-b nhba fusion protein /recombinant neisseria meningitidis group-b nada protein /recombinant neisseria meningitidis group b fhbp fusion protein /outer membrane vesiclesfrom neisseria meningitidis group-b strain nz98 / 254 measured as amount of total protein containing the pora p1.4 | rmenb

Organizations (18)

Research & Development (18)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (15)

Approved Indications (1)


 

Meningococcal Vaccines (approved 2015)

Experimental Indications - Clinical Trial Phases 1-4 (15)


 

Communicable Diseases (Phase 2)

Healthy Volunteers (Phase 3)

HIV (Phase 4)

HIV Infections (Phase 4)

Infant, Premature, Diseases (Phase 4)

Meninges (Phase 3)

Meningitis, Meningococcal (Phase 4)

Meningococcal Infections (Phase 4)

Meningococcal Vaccines (Phase 3)

Neisseria meningitidis (Phase 2)

Respiratory Syncytial Virus Infections (Phase 1)

Risk-Taking (Phase 3)

Splenectomy (Phase 3)

Unsafe Sex (Phase 3)

Vaccination (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 45
  • # of Trial Organizations: 18

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue